Role of NADPH Oxidase 4 on Dry Eye Syndrome in Mice

Mian Guo1,2,3,4, Taixiang Liu1,2,3,4, Yuan Miao1,2,3,4

  • 1Department of Ophthalmology, Affiliated Hospital of Zunyi Medical University, Zunyi, Guizhou Province, China.

Insights

Concanavalin A-induced dry eye syndrome (DES) in mice involves NADPH oxidase 4 (NOX4)-mediated inflammation. Inhibiting NOX4 reversed key indicators, suggesting NOX4

Area of Science:

  • Ophthalmology
  • Immunology
  • Molecular Biology

Background:

  • Dry eye syndrome (DES) is a prevalent ocular surface disease characterized by inflammation and damage.
  • NADPH oxidase 4 (NOX4) is implicated in inflammatory processes, but its specific role in DES remains unclear.

Purpose of the Study:

  • To investigate the role of NOX4-mediated inflammation in concanavalin A (ConA)-induced dry eye syndrome (DES) in a mouse model.
  • To determine if interfering with NOX4 can ameliorate the pathological features of DES.

Main Methods:

  • Concanavalin A (ConA) was used to induce DES in mice, with a NOX4 interference group established using adenovirus.
  • Tear secretion, conjunctival damage, corneal surface morphology, and goblet cell counts were assessed.
  • The expression of NOX4, NLRP3 inflammasome components (NLRP3, IL-1β), and MUC5AC was analyzed via immunohistochemistry.

Main Results:

  • ConA-induced DES mice exhibited reduced tear secretion, increased conjunctival/corneal damage, and elevated NOX4, NLRP3, and IL-1β expression.
  • MUC5AC expression was decreased in the DES model.
  • Interference with NOX4 led to a reversal of these pathological changes, improving tear secretion and reducing inflammation.

Conclusions:

  • NOX4-mediated inflammation plays a significant role in the pathogenesis of ConA-induced dry eye syndrome.
  • Targeting NOX4 presents a potential therapeutic strategy for managing dry eye disease.

Related Concept Videos